Sachs Associates would like to say we enjoyed hosting you at our 10th Annual Oncology Innovation Forum (#Sachs_OIF). We would like to thank those who joined us in-person in Chicago and those who participated virtually. The forum successfully brought together leaders in oncology to discuss the current market, facilitating numerous new and renewed interactions among participants. We extend our thanks to all the speakers, presenters, sponsors, and audience members who made this success possible.
To view photos from the event, please navigate to the 'PHOTOS’ tab. To watch a session on-demand, please navigate to the 'RECORDINGS' or ‘AGENDA’ tab and select the session that you want to view. To view showcases, please click on the 'PRESENTERS' tab. Each company has a showcase button, which will allow you to view their presentation. The Online Meeting System and event portal will be available for review, messaging people, and exchanging contacts with people you did not have a chance to meet until the 1st of July 2024.
We look forward to welcoming you again to our future events!
BRONZE SPONSOR:
Presenting Companies Included:
Carina Biotech
Geneos Therapeutics, Inc.
Lisata Therapeutics, Inc.
Speakers and Chairs Included:
Brad Loncar
Founder, BiotechTV
Evonne Sepsis
Managing Director, ESC Advisors
Jacob Plieth
Senior Reporter, ApexOnco
Jay Olson
Managing Director & Senior Analyst, Oppenheimer & Co. Inc.
Jeffrey Bockman
EVP Expert Advisor, Oncology, Lumanity Head, Oncology Center of Excellence, Lumanity
Joel Sandler
Associate Partner, Ipsos Healthcare Advisory Service
Kaveri Pohlman
Managing Director - Senior Research Analyst, Clear Street LLC
Michael Kingston
Managing Director, Global Co-Head of Biopharma & Co-Head of North American Healthcare, Lazard Ltd.
Michael Rice
Expert Advisor, SVP, Cell & Gene Therapy, Lumanity
Paul Rennert
President & CSO, Aleta Biotherapeutics
Peter Sandor
EVP Head of Corporate Strategy, Astellas Pharma, Inc.
Sharon Chan
VP JLABS Asia Pacific, Johnson & Johnson
Andreas Pahl
CEO, Heidelberg Pharma AG
Benjamin Burnett
Equity Research Analyst, Stifel
Colette Lipp
Senior Director, Global BD Oncology & Immuno-Oncology, Merck KGaA, Darmstadt, Germany
David G. Benathan
VP, Head BD&L Transactions Oncology & RLT, Novartis Pharma AG
Deborah Rathjen
Managing Director & CEO, Carina Biotech Limited
Devang Bhuva
SVP, Corporate Development & Alliance Management, Gilead Sciences, Inc.
Gregor Fachinger
VP, Head of Oncology & Immuno-Oncology Business Development, Merck KGaA, Darmstadt, Germany
James Barlow
President & CEO, ImmunoGenesis, Inc.
Jean-Pierre Latere
CEO, EsoBiotec
John DeYoung
VP, Worldwide Business Development, Pfizer, Inc.
John Flavin
Founder & CEO, Portal Innovations, LLC
Jun Xu
Executive Director - Therapy Acceleration Program Lead, The Leukemia & Lymphoma Society
Margarita Chavez
Venture Partner, Wellington Partners
Matthew Price
Co-Founder, EVP & Chief Operating Officer, Promontory Therapeutics Inc.
Maurits Geerlings
President & CEO, NanoCell Therapeutics, Inc.
Max Nisen
Equity Research Analyst, Pharma & Biotech, Bloomberg Intelligence
Michael Salgaller
Supervisory Specialist, National Institutes of Health (NIH)
Nadim Ahmed
President & CEO, Cullinan Therapeutics, Inc.
Nicole Fay
Director of Pharmacology, Nutcracker Therapeutics, Inc.
Niels Emmerich
VP, Search & Evaluation & Global Alliances, AbbVie, Inc.
Niranjan Sardesai
Founder, President & CEO, Geneos Therapeutics, Inc.
Omari Wise
Vice President Business Development, Amgen, Inc.
Pete DeMuth
Chief Scientific Officer, Elicio Therapeutics, Inc.
Polly Brown
VP, Head of Business Development, Oncology R&D, AstraZeneca
Raven Lin
Co-Founder & CEO, Pilatus Biosciences SA
Sath Nirmalananthan
Chief Financial Officer, Scancell Holdings PLC
Susie Harborth
Chief Business Officer, Breakthrough Properties
Uciane Scarlett
Principal Venture Capitalist, MPM BioImpact
Upendra Marathi
President & CEO, 7 Hills Pharma Inc.
Vivek Abraham
Director, Oncology Search & Evaluation, AbbVie, Inc.
Xavier Avat
Chief Business Officer, Moffitt Cancer Center
Yuval Cohen
CEO, Corbus Pharmaceuticals Holdings, Inc.